Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimalarial drug efficacy study in Myanmar
ACTRN12614000216617Phase 4Recruiting
- Sponsor
- Department of Medical Research
- Start
- Jan 2014
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artemether, lumefantrine, dihydroartemisinin, piperaquine and chloroquine in malaria and Malaria (3 arms), sponsored by Department of Medical Research. Primary endpoints: Study endpoint classification, Early treatment failure and 3 more. Started Jan 2014; status: recruiting.
02
Drugs
artemetherlumefantrinedihydroartemisininpiperaquinechloroquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12614000216617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000216617.